None listed
Conditions
Brief summary
To determine whether slow loaded breathing (SLB) training combine with minimal load at 5 cmH2O and 7 cmH2O has advantage of reducing resting home blood pressure and heart rate compared to normal daily activities in patient with essential hypertension. Materials and Methods: In this randomized controlled trial, forty-five patients with essential hypertension stage I or II. The training program was performed slow breathing training combine with minimal load at 5 cmH2O and 7 cmH2O at home for 30 minutes/session, 2 sessions/day with at least 30 minutes rest between sessions, every day for 8 weeks. Control (CON) group continued with normal daily activities. Measurement of resting blood pressure and heart rate at home and laboratory before and after the training on a daily basis.
Interventions
This intervention will be delivered by a physiotherapist. It involves slow breathing training using a minimal load of either 5 cmH2O or 7 cmH2O, which was set by the depth of water in the bottle and controlled respiratory rate at 6 breaths per minute. The paced breathing was first practiced using metronome in the laboratory and create familiarity with training until patients comfortably while training at 1 week before starting the home training program. The training program was performed slow breathing training combine with minimal load at 5 cmH2O and 7 cmH2O at home for 30 minutes/session, 2 sessions/day with at least 30 minutes rest between sessions, every day for 8 weeks. Logbook used to assess or monitor adherence to the intervention. The training load of 5 cmH2O and 7 cmH2O were applied to separate groups of participants.
Sponsors
Study design
Eligibility
Inclusion criteria
Inclusion criteria were subjects aged 30 to 59 years were I to II stage of essential hypertension, defined as average SBP 140-179 mmHg and DBP 90-109 mmHg based on recommendation of JNC-VII (Chobanian AV et al. 2007) with stable controlled hypertension before the study, good communication and co-operation.
Exclusion criteria
Exclusion criteria were secondary hypertension, use beta-blockers, heart disease (coronary artery disease, myocardial infarction, etc.), respiratory disease (asthma, chronic bronchitis), neuromuscular disease (muscle weakness, cerebrovascular disease, etc.), renal disease, metabolic syndrome, aortic aneurysm.